Craig Brunkhorst

Title: Innovations by Craig Brunkhorst in Copper-64 Research

Introduction

Craig Brunkhorst, an accomplished inventor based in St. Louis, MO, has made significant contributions to the field of nuclear medicine through his innovative work with copper-64. With a total of nine patents to his name, Brunkhorst has played a crucial role in advancing the understanding and utilization of this important radioisotope.

Latest Patents

Among his latest patents, Brunkhorst has developed a purification process for the preparation of non-carrier added copper-64. This involves the creation of compositions containing high levels of specific activity copper-64. The notable compositions comprise from about 2 Ci to about 15 Ci of copper-64, achieving specific activities up to approximately 3800 mCi copper-64 per microgram. The process he devised entails bombarding a nickel-64 target with a low energy, high current proton beam, followed by purifying the copper-64 using ion exchange chromatography or a hybrid method of extraction and ion exchange chromatography.

Another significant patent focuses on copper-64 compositions and formulations, detailing methods for preparing these compositions and administering them to patients in need. This innovative approach enhances the therapeutic potential of copper-64 in clinical settings.

Career Highlights

Brunkhorst's work is conducted at Curium US LLC, where he has utilized his expertise to push the boundaries of copper-64 technology. His career is marked by a commitment to research and innovation, contributing to advancements that have profound implications for medical treatments involving radiopharmaceuticals.

Collaborations

Craig collaborates closely with notable coworkers, including Lauren Radford and Brian Regna, who share his vision for enhancing the applications of copper-64 in healthcare. Together, they form a dynamic team dedicated to finding groundbreaking solutions in, nuclear medicine.

Conclusion

Craig Brunkhorst's inventions and patents are at the forefront of copper-64 research, underscoring his role as a pivotal figure in the field. His ongoing contributions not only enhance scientific understanding but also pave the way for improved patient outcomes in nuclear medicine. His work exemplifies the spirit of innovation and collaboration, driving forward the potential of medical technologies.